Lopinavir/ritonavir (Daré Bioscience)

洛匹那韦/利托那韦 (Daré Bioscience)

Report date: 2025/02/19 16:44:04

Base Information

Drug NameLopinavir/ritonavir (Daré Bioscience)
Drug Alias NameLopinavir and ritonavir combination soft gel vaginal insert (Daré Bioscience)R-131-2DARE-CINR 131DARE-HPV +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesDouglas Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaré Bioscience IncDouglas Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A